world
health
organ
publish
alcoholbas
formul
use
healthcar
set
outbreakassoci
infect
inactiv
efficaci
product
determin
emerg
virus
studi
evalu
virucid
activ
product
compar
analysi
zika
viru
zikv
ebola
viru
ebov
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
viral
pathogen
envelop
virus
could
effici
inactiv
formul
implic
use
healthcar
system
viral
outbreak
situat
hygien
hand
antisepsi
one
import
measur
prevent
healthcareand
outbreakassoci
viral
infect
reduc
spread
infect
biocid
proven
virucid
efficaci
readili
avail
world
health
organ
propos
guidelin
hand
hygien
health
care
use
alcoholbas
hand
rub
formul
formul
ii
surgic
hygien
hand
disinfect
healthcar
set
reduc
transmiss
pathogen
hand
howev
limit
data
exist
efficaci
disinfect
includ
formul
novel
virus
emerg
recent
outbreak
differ
part
world
recent
zika
viru
zikv
flaviviru
discov
origin
africa
rais
consider
intern
concern
largest
complex
outbreak
ebola
viru
ebov
filoviru
spread
mainli
contact
bodi
fluid
symptomat
patient
contamin
surfac
occur
west
africa
one
year
previous
novel
coronaviru
cov
name
middl
east
respiratori
syndrom
mer
emerg
preced
sever
acut
respiratori
syndrom
sar
virus
caus
acut
respiratori
diseas
human
display
high
casefat
rate
previous
evalu
formul
quantit
suspens
test
chemic
disinfect
antisept
human
medicin
use
differ
nonenvelop
model
virus
observ
formul
demonstr
better
activ
formul
ii
nonenvelop
virus
howev
time
neither
formul
met
requir
virucid
activ
polioviru
accord
european
guidelin
surgic
hand
treatment
accord
european
norm
sinc
formul
modifi
higher
alcohol
content
lower
glycerol
concentr
fulfil
guidelin
requir
studi
evalu
first
time
modifi
whorecommend
alcoholbas
formul
differ
envelop
virus
includ
emerg
zikv
ebov
sarscov
merscov
perform
compar
inactiv
analysi
emerg
virus
import
refer
virus
overview
virus
cell
cultur
system
use
studi
given
supplementari
tabl
hepat
c
viru
hcv
chimer
viru
gener
human
hepatoma
cell
line
previous
describ
african
lineag
zikv
strain
isol
uganda
propag
use
cell
like
merscov
strain
emc
sarscov
strain
frankfurt
bovin
cov
bcov
produc
human
glioblastoma
astrocytoma
cell
human
influenza
viru
produc
madindarbi
canin
kidney
epitheli
cell
mdck
modifi
vaccinia
ankara
strain
mva
produc
babi
hamster
kidney
cell
ebola
viru
propag
vero
cell
previous
describ
ebola
viruslik
particl
encod
luciferas
gener
use
cell
previous
report
gener
cell
line
cultur
dulbecco
modifi
minim
essenti
medium
eagl
minimum
essenti
medium
supplement
fetal
calf
serum
addit
supplementari
tabl
one
part
volum
test
viru
suspens
part
volum
organ
load
mix
part
volum
formul
differ
concentr
addit
inform
provid
supplementari
data
concentr
formul
reach
half
maxim
viru
inactiv
effect
concentr
ec
determin
use
nonlinear
regress
use
robust
fit
method
normal
tissu
cultur
infecti
dose
tcid
data
implement
graphpad
prism
version
window
mean
tcid
individu
experi
standard
deviat
mean
also
calcul
use
graphpad
prism
signific
differ
mean
ec
obtain
virus
formul
ii
test
use
wilcoxon
matchedpair
sign
rank
test
p
hepat
c
viru
zikv
belong
famili
flavivirida
supplementari
tabl
transmit
environ
differ
rout
wherea
hcv
bloodborn
viru
transmiss
zikv
occur
mainli
mosquito
import
common
vector
aed
genu
howev
mode
transmiss
includ
sexual
transmiss
report
determin
efficaci
formul
ii
hcv
zikv
incub
virus
second
formul
final
concentr
rang
figur
case
hcv
viral
titer
start
declin
concentr
formul
ii
formul
reduc
background
level
concentr
formul
formul
ii
respect
figur
depict
figur
dosedepend
reduct
viral
titer
also
observ
zikv
figur
importantli
viral
titer
tcid
ml
control
decreas
undetect
level
formul
concentr
wherea
concentr
requir
complet
inactiv
forumul
ii
coronaviru
sever
acut
respiratori
syndrom
coronoaviru
next
investig
suscept
emerg
respiratori
cov
formul
experiment
suspens
assay
setup
refer
cov
cultiv
lower
biosafeti
level
includ
bcov
natur
infect
cattl
depict
supplementari
figur
formul
ii
concentr
suffici
complet
inactiv
bcov
wherea
formul
higher
concentr
least
requir
supplementari
figur
similar
inactiv
profil
could
observ
merscov
figur
sarscov
figur
demonstr
high
suscept
emerg
cov
formul
furthermor
result
implic
bcov
valid
surrog
viru
inactiv
studi
merscov
sarscov
work
infecti
ebov
restrict
biosafeti
level
laboratori
significantli
limit
studi
virus
watt
et
al
report
novel
life
cycl
model
approach
ebov
perform
biosafeti
level
laboratori
inactiv
transcriptionand
replicationcompet
viruslik
particl
trvlp
formul
show
dosedepend
reduct
trvlp
report
activ
increas
formul
ii
concentr
figur
next
test
full
infecti
ebov
cultur
biosafeti
level
suscept
formul
potenti
usag
outbreak
situat
interestingli
viral
titer
tcid
ml
control
reduc
background
level
concentr
formul
ii
formul
show
superior
virucid
activ
formul
ii
compar
formul
figur
also
includ
influenza
viru
inactiv
experi
import
caus
viral
respiratori
epidem
pandem
could
inactiv
concentr
formul
formul
ii
supplementari
figur
furthermor
mva
studi
suscept
formul
chosen
test
viru
envelop
virus
european
guidelin
line
ebov
similar
inactiv
profil
could
observ
increas
formul
ii
concentr
supplementari
figur
base
obtain
virucid
activ
formul
differ
envelop
virus
next
analyz
inactiv
profil
compar
analysi
figur
suscept
virus
formul
bovin
emerg
cov
bcov
sarscov
merscov
zikv
figur
shift
increas
forum
concentr
stabl
virus
includ
full
infecti
ebov
trvlp
exclud
analysi
hcv
figur
highest
alcoholbas
concentr
formul
requir
mva
display
nearli
ident
inactiv
respons
curv
figur
result
isopropanolbas
formul
ii
depict
figur
demonstr
similar
pattern
suscept
differ
envelop
virus
obviou
shift
toward
lower
concentr
figur
cov
zikv
show
highest
suscept
formul
ii
wherea
hcv
ebov
mva
demonstr
resist
inactiv
profil
figur
also
directli
compar
perform
formul
determin
concentr
product
reach
ec
supplementari
figur
world
health
organ
formul
ii
show
significantli
higher
virucid
activ
differ
virus
compar
formul
p
summari
cov
zikv
show
highest
suscept
formul
ebola
viru
hcv
observ
less
suscept
cov
wherea
mva
stabl
virus
addit
formul
ii
demonstr
higher
virucid
effect
compar
formul
recommend
formul
guidelin
hand
hygien
health
care
document
propos
use
cheap
alcoholbas
hand
rub
reduc
transmiss
pathogen
aim
studi
analyz
virucid
efficaci
product
particularli
emerg
reemerg
virus
caus
sever
epidem
recent
past
importantli
formul
inactiv
test
virus
includ
zikv
ebov
emerg
cov
suspens
test
exposur
time
implic
formul
ii
test
efficaci
inactiv
ebov
transcriptionand
replicationcompet
viruslik
particl
trvlp
ebov
b
biocid
concentr
rang
exposur
time
second
inactiv
assay
part
viru
part
organ
load
mix
part
biocid
determin
ebov
trvlp
infect
luciferas
activ
measur
hour
later
ebov
residu
infect
determin
limit
dilut
assay
viral
titer
display
tissu
cultur
infecti
dose
tcid
valu
cytotox
calcul
analog
determin
viru
titer
tcid
ml
depict
dash
line
mean
independ
experi
standard
deviat
shown
normal
valu
percentag
inactiv
viral
infect
yaxi
plot
formul
c
ii
doserespons
curv
xaxi
log
represent
virus
list
panel
rank
least
stabl
normal
nonlinear
regress
calcul
data
perform
use
graphpad
prism
version
window
abbrevi
nd
detect
usabl
formul
viral
outbreak
situat
case
zikv
specif
viral
inactiv
data
lack
consequ
disinfect
guidelin
base
data
obtain
member
flavivirus
far
recent
studi
et
al
report
zikv
inactiv
classic
inactiv
method
includ
ultraviolet
light
zika
viru
readili
reduc
viral
titer
formul
similar
member
famili
flavivirida
hcv
find
support
earlier
analys
environment
stabil
inactiv
profil
hcv
show
strong
virucid
effect
main
formul
ingredi
ethanol
isopropanol
ebov
limit
data
efficaci
virucid
product
avail
virus
requir
high
biosafeti
level
laboratori
center
diseas
control
prevent
advis
suitabl
disinfect
solut
includ
sodium
hypochlorid
well
glutaraldehyd
phenol
disinfect
ebov
inactiv
compar
inactiv
analys
virus
test
reveal
cov
particular
sarscov
suscept
virus
formul
treatment
degre
suscept
differ
virus
formul
like
depend
specif
surfac
properti
lipophil
envelop
respect
viru
could
show
compar
inactiv
analysi
mva
show
highest
stabil
alcoholbas
inactiv
higher
concentr
formul
ii
requir
compar
cov
zikv
ebov
result
confirm
mva
model
surrog
viru
envelop
virus
test
chemic
disinfect
antisept
human
medicin
test
nonenvelop
virus
like
noro
polio
adenoviru
far
higher
level
resist
formul
observ
probabl
due
hydrophil
charact
virus
interestingli
formul
superior
compar
formul
ii
inactiv
nonenvelop
virus
wherea
studi
opposit
effect
occur
formul
ii
show
higher
virucid
activ
envelop
virus
discrep
explain
presenc
viru
envelop
like
render
envelop
virus
suscept
isopropanolbas
formul
ii
compar
ethanolbas
formul
furthermor
isopropanol
carbon
ethanol
give
greater
lipophil
properti
higher
virucid
activ
lipophil
virus
conclus
whorecommend
alcoholbas
formul
valid
differ
envelop
virus
strong
virucid
effect
emerg
pathogen
includ
zikv
ebov
sarscov
merscov
could
demonstr
implic
usabl
formul
healthcar
outbreakassoci
viral
infect
supplementari
materi
avail
journal
infecti
diseas
onlin
consist
data
provid
author
benefit
reader
post
materi
copyedit
sole
respons
author
question
comment
address
correspond
author
